What is CapsoVision?
CapsoVision, Inc., operating from Silicon Valley, California, is a privately held company dedicated to advancing medical technologies. Its core mission revolves around empowering physicians and patients with innovative solutions that bolster diagnostic confidence and improve clinical outcomes. The company's flagship product, the CapsoCam Plus capsule endoscopy system, is currently distributed in over 70 countries, demonstrating a significant global reach and market penetration. This focus on cutting-edge diagnostic tools positions CapsoVision as a key player in the medical device sector.
How much funding has CapsoVision raised?
CapsoVision has raised a total of $74.2M across 11 funding rounds:
Private Equity
$2.5M
Private Equity
$1.5M
Private Equity
$589K
Private Equity
$3.7M
Private Equity
$15.9M
Private Equity
$4.6M
Debt
$350K
IPO
$27.5M
Stock/Share Issuance
$14M
Private Equity (2011): $2.5M, investors not publicly disclosed
Private Equity (2011): $1.5M, investors not publicly disclosed
Private Equity (2012): $589K, investors not publicly disclosed
Private Equity (2012): $3.7M, investors not publicly disclosed
Private Equity (2014): $15.9M, investors not publicly disclosed
Private Equity (2016): $4.6M, investors not publicly disclosed
Debt (2020): $350K featuring PPP
IPO (2025): $27.5M, investors not publicly disclosed
Stock/Share Issuance (2026): $14M, investors not publicly disclosed
What's next for CapsoVision?
With a history of consistent private equity backing and recent strategic investment, CapsoVision appears poised for further expansion and technological development. The company's trajectory suggests a mature stage of growth, likely focusing on scaling its global operations, enhancing its product offerings, and potentially exploring new market segments within diagnostic medicine. The substantial total funding indicates a strong foundation for continued innovation and market leadership in capsule endoscopy and related fields.
See full CapsoVision company page
